Cancer Research Training and Education Coordination

癌症研究培训和教育协调（CRTEC）-摘要 Karmanos癌症研究所（KCI）提供广泛的癌症研究培训和教育计划， 跨越所有职业阶段。Michele Cote博士（PSDR），教育副中心主任，领导KCI的CRTEC 努力除了确定，促进和支持大学赞助的培训活动，科特博士 （PSDR）协调KCI的癌症特异性计划。在CRTEC教育咨询公司的支持下 理事会成员，每个人都在一个特定的领域或培训窗口的专业知识，科特博士（PSDR）担任 在整个职业生涯轨迹中为学员提供主要联系点。CRTEC的一个关键组成部分是评估 支持的培训活动的有效性，并确定差距和机会，以加强KCI 在整个范围内进行培训。 KCI的教育工作跨越教育和培训的连续性，包括努力集中在高中 学生，本科生，研究生和医科学生，博士后实习生，住院医生和研究员， 初级教师、终身教师和社区医疗保健提供者。CRTEC的努力得到了十个活跃的 培训项目直接费用共计895 210美元。有几个是从马瑟利博士（MT）领导的T32中成长起来的。 （T32CA009531）。这个癌症生物学的培训项目已经连续资助了三年多， 几十年自2015年以来，已有24名学生通过T32获得支持，其中5名学生还获得了 支持F30或F31。KCI的新努力包括在2019年推出focuStem，这是一个计划， 在KCI领导层的支持下，由一名高中生为高中生开发。wrd第一个 一年来，五所学校和149名学生参加了为期一天的计划（37%的非洲裔美国人，30%的非裔美国人）。 西班牙裔白色，27%阿拉伯裔美国人，4%西班牙裔和2%其他种族;超过50%的女性）。的新成员 我们努力接触高中生的是发现治愈高中实习计划（DTCHIP） （R25 HD 072591）由Gil莫尔博士（TBM）领导，将于2020年夏季开始招募。

CANCER RESEARCH TRAINING AND EDUCATION COORDINATION (CRTEC) – ABSTRACT Karmanos Cancer Institute (KCI) provides extensive cancer research training and educational programs that span all career stages. Dr. Michele Cote (PSDR), Associate Center Director for Education, leads KCI’s CRTEC efforts. In addition to identification, promotion, and support of University-sponsored training activities, Dr. Cote (PSDR) coordinates the cancer-specific programs at KCI. With the support of CRTEC Education Advisory Council members, each with expertise in a particular field or window of training, Dr. Cote (PSDR) serves as the main point of contact for trainees across the career trajectory. A key component of the CRTEC is to evaluate the effectiveness of the supported training activities, and identifying gaps and opportunities to enhance KCI training efforts across the spectrum. KCI’s education efforts span the education and training continuum including efforts focused on high school students, undergraduate students, graduate and medical students, post-doctoral trainees, residents and fellows, junior faculty, tenured faculty and community healthcare providers. CRTEC efforts are supported by ten active training projects totaling $895,210 direct costs. Several have grown out of a T32 led by Dr. Matherly (MT) (T32CA009531). This training program in the biology of cancer that has been continuously funded for over three decades. Since 2015, 24 students have been supported via the T32, five of whom were also awarded subsequent F30 or F31 support. Novel efforts at KCI include the launch of focuSStem in 2019, a program developed by a high school student, for high school students, with support from KCI leadership. In its inaugural year, five schools and 149 students have participated in the day-long program (37% African American, 30% non- Hispanic white, 27% Arab American, 4% Hispanic and 2% other races; over 50% females). A recent addition to our efforts in reaching high school students is the Discovery to Cure High School Internship Program (DTCHIP) (R25HD072591) led by Dr. Gil Mor (TBM) which will begin recruiting in the summer of 2020.